Evidence map›Paper›PMID 38649271›Full record

ArticleThorax2024

Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study.

Olivia C Leavy, Leticia Kawano-Dourado, Iain D Stewart, Jennifer K Quint, Joshua J Solomon, Raphael Borie, Bruno Crestani, Louise V Wain, Gisli Jenkins, Philippe Dieudé and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Thorax, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Genomic and Serological Rheumatoid Arthritis Biomarkers,Annals of the American Thoracic Society · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Olivia C LeavyDepartment of Population Health Sciences, University of Leicester, Leicester, UK.ORCID 0000-0002-1503-5535
Leticia Kawano-DouradoHcor Research Institute, Hcor, São Paulo, Brazil.ORCID 0000-0003-0784-1331
Iain D StewartNational Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0002-1340-2688
Jennifer K QuintNational Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0003-0149-4869
Joshua J SolomonDivision of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, Colorado, USA.
Raphael BorieService de Pneumologie A Hôpital Bichat, APHP, Paris, France.ORCID 0000-0002-9906-0024
Bruno CrestaniService de Pneumologie A Hôpital Bichat, APHP, Paris, France.
Louise V Wain *Department of Population Health Sciences, University of Leicester, Leicester, UK.ORCID 0000-0003-4951-1867
Gisli Jenkins *National Heart and Lung Institute, Imperial College London, London, UK gisli.jenkins@imperial.ac.uk.ORCID 0000-0002-7929-2119
Philippe Dieudé *Service de Pneumologie A Hôpital Bichat, APHP, Paris, France.
Cosetta Minelli *National Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0001-9166-3958
Inserm · FRNIHR Imperial Biomedical Research Centre · GBUniversity of Leicester · GBImperial College London · GBLung Institute · USNational Jewish Health · USUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA usual interstitial pneumonia (UIP) pattern of lung injury is a key feature of idiopathic pulmonary fibrosis (IPF) and is also observed in up to 40% of individuals with rheumatoid arthritis (RA)-associated interstitial lung disease (RA-ILD). The RA-UIP phenotype could result from either a causal relationship of RA on UIP or vice versa, or from a simple co-occurrence of RA and IPF due to shared demographic, genetic or environmental risk factors.

methodsWe used two-sample bidirectional Mendelian randomisation (MR) to test the hypothesis of a causal effect of RA on UIP and of UIP on RA, using variants from genome-wide association studies (GWAS) of RA (separately for seropositive (18 019 cases and 991 604 controls) and seronegative (8515 cases and 1 015 471 controls) RA) and of IPF (4125 cases and 20 464 controls) as genetic instruments. Sensitivity analyses were conducted to assess the robustness of the results to violations of the MR assumptions.

findingsIPF showed a significant causal effect on seropositive RA, with developing IPF increasing the risk of seropositive RA (OR=1.06, 95% CI: 1.04 to 1.08, p<0.001) which was robust under all models. For the MR in the other direction, seropositive RA showed a significant protective effect on IPF (OR=0.93; 95% CI: 0.87 to 0.99; p=0.032), but the effect was not significant when sensitivity analyses were applied. This was likely because of bias due to exclusion of patients with RA from among the cases in the IPF GWAS, or possibly because our genetic instruments did not fully capture the effect of the complex human leucocyte antigen region, the strongest RA genetic risk factor.

interpretationOur findings support the hypothesis that RA-UIP may be due to a cause-effect relationship between UIP and RA, rather than due to a coincidental occurrence of IPF in patients with RA. The significant causal effect of IPF on seropositive RA suggests that pathomechanisms involved in the development of UIP may promote RA, and this may help inform future guidelines on screening for ILD in patients with RA.

Indexed as

Arthritis, RheumatoidGenome-Wide Association StudyIdiopathic Pulmonary FibrosisMendelian Randomization AnalysisFemaleGenetic Predisposition to DiseaseHumansMaleRisk FactorsIdiopathic pulmonary fibrosisInterstitial FibrosisRheumatoid lung disease

Identifiers

PMID38649271
PMCPMC11137470
OpenAlexW4394995890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.